Clinical Trials in Chicago

Showing 6121-6140 of 15,574 trials

A Study Evaluating the Safety, Tolerability, and Effect on Microvascular Obstruction of Intravenous Temanogrel in Adult Participants Undergoing Percutaneous Coronary Intervention

NCT04848220

The purpose of this study is to determine whether intravenous temanogrel is a safe and effective treatment for microvascular obstruction (MVO) in adult participants undergoing percutaneous coronary intervention (PCI).

Microvascular Obstruction

Pfizer29 participantsStarted May 2021

Long Beach, California, United States • Palo Alto, California, United States • Chicago, Illinois, United States +9 more locations

Active Not RecruitingPhase 22.2 miles

Aggressive Smoldering Curative Approach Evaluating Novel Therapies and Transplant

NCT03289299

This study evaluates the use of carfilzomib, lenalidomide, daratumumab, and dexamethasone in subjects with high-risk smoldering multiple myeloma (SMM). Subjects will receive treatment in 3 phases - induction (6 cycles), consolidation (6 cycles), and maintenance (12 cycles). Each cycle is 28 days.

Smoldering Multiple Myeloma

International Myeloma Foundation87 participantsStarted May 2018

Tampa, Florida, United States • Chicago, Illinois, United States • Indianapolis, Indiana, United States +7 more locations

A Study Evaluating the Safety, Tolerability, and Effect on Microvascular Obstruction of Intravenous Temanogrel in Adult Participants Undergoing Percutaneous Coronary Intervention

Aggressive Smoldering Curative Approach Evaluating Novel Therapies and Transplant

Find Trials by Condition in Chicago

Peer Navigators to Address Obesity-Related Concerns for African Americans With Serious Mental Illness

Effectiveness and Implementation of a Mindfulness Intervention for Depressive Symptoms Among Adults in a FQHC

Phase II Trial of Combination Immunotherapy With NeuVax and Trastuzumab in High-risk HER2+ Breast Cancer Patients

Micronized dHACM vs. Saline in the Treatment of Osteoarthritis of the Knee

Nivolumab Maintenance Therapy After Autologous Stem Cell Transplant in Hodgkin Lymphoma Pts at Relapse/Progression Risk

Open Label Study of R788 in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP)

Approaches and Decisions for Acute Pediatric TBI Trial

A Study of Efficacy and Safety of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis

20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study of a 4-Dose Series in Healthy Infants

Durvalumab and Tremelimumab and Best Supportive Care vs Best Supportive Care in Patients With Advanced Colorectal Cancer

A Study to Evaluate the Efficacy and Safety of Maralixibat in Subjects With Progressive Familial Intrahepatic Cholestasis (MARCH-PFIC)

OCS Liver PROTECT Continued Access Protocol (CAP) Continuation Post-Approval Study

iCanCope With Sickle Cell Pain

Phase I-Ib/II Study of MBG453 as Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies

Diabetes Pump With Predictive Low Glucose Suspend Pivotal Trial

Study to Evaluate the Safety and Activity (Including Distribution) of 177Lu-3BP-227 in Subjects With Solid Tumours Expressing Neurotensin Receptor Type 1.

Eltrombopag Combined With Cyclosporine as First Line Therapy in Patients With Severe Acquired Aplastic Anemia

International Lung Screen Trial (ILST)